Related Experiment Videos
Impact of genetic variation on perioperative bleeding
Jochen D Muehlschlegel1, Simon C Body
1Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. jmuehlschlegel@partners.org
American Journal of Hematology
|May 30, 2008
Summary
Genetic factors significantly influence perioperative bleeding risks. Understanding these genetic variations can help identify patients prone to bleeding, especially after cardiac surgery, improving patient outcomes.
Area of Science:
- Genetics
- Cardiovascular Surgery
- Anesthesiology
Background:
- Perioperative bleeding is a complex issue with significant patient and healthcare implications.
- Current understanding of the genetic underpinnings of perioperative bleeding is limited.
- Advancements in genomic technology and large patient databases offer new opportunities to study genetic influences.
Purpose of the Study:
- To review the current knowledge on genetic factors influencing perioperative bleeding.
- To explore specific gene polymorphisms associated with bleeding risk.
- To discuss the implications of these genetic factors, particularly in cardiac surgery.
Main Methods:
- Literature review focusing on genetic polymorphisms.
- Analysis of studies investigating gene variations related to hemostasis and cardiovascular function.
- Synthesis of findings on the impact of genetics on bleeding beyond surgical factors.
Main Results:
- Identified key gene polymorphisms in platelet receptors, plasminogen activator inhibitor, and angiotensin pathways.
- Highlighted the role of these genetic variations in modulating bleeding risk.
- Emphasized the potential for genetic profiling to predict bleeding complications.
Conclusions:
- Genetic variations play a crucial role in perioperative bleeding.
- Further research into genetic influences can lead to personalized risk assessment and management strategies.
- Understanding these genetic factors is vital for optimizing patient care, especially in high-risk settings like cardiac surgery.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...